In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Beaufour Ipsen: Gearing up to Go Public

Executive Summary

Family-owned Beaufour Ipsen has kept its cards to its chest for most of its 70-year history. Now, though, France's third largest independent pharmaceutical company is gearing up for a big US push-and to go public.
Advertisement

Related Content

Pierre Fabre: Time to Reap R&D Rewards In-House
Europe's Flavors of Sustainable BioPharma
Building a Sustainable BioPharma Industry--the European Way
Roche Signs Up Ipsen--Again
Roche Boosts Beaufour
A Tepid Wedding, Now A Possible Divorce

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV004587

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel